Letter to the editor regarding European Headache Federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

• Published in: Journal of headache and pain Vol. 20; no. 1; pp. 22 - 2
• Main Authors: Nichols, Russell, Skljarevski, Vladimir, Dell’Agnello, Grazia, Hundemer, Hans-Peter, Aurora, Sheena K.
• Format: Journal Article
• Language: English
• Published: Milan Springer Milan 01.03.2019; Springer Nature B.V; BMC
• Subjects: Adolescents; Adults; Anatomy & physiology; Antibodies, Monoclonal - administration & dosage; Calcitonin; Calcitonin Gene-Related Peptide - antagonists & inhibitors; Calcitonin Gene-Related Peptide Receptor Antagonists - administration & dosage; Children; Children & youth; Clinical Trials, Phase III as Topic - standards; Comparative studies; Europe - epidemiology; Headache; Headache - drug therapy; Headache - epidemiology; Humans; Internal Medicine; Letter to the Editor; Medicine; Medicine & Public Health; Migraine; Migraine Disorders - epidemiology; Migraine Disorders - prevention & control; Monoclonal antibodies; Neurology; Pain; Pain Medicine; Practice Guidelines as Topic - standards; Receptors, Calcitonin Gene-Related Peptide; Europe

The present report provides a detailed head to head comparative study of migraine pain location at onset and during established headache between children and adults belonging to the same ethnic group. Migraine pain location in 200 children and adolescents had already been reported (Chakravarty et al...